These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16452951)

  • 1. Endangered species: time to raise the devil.
    Dennis C
    Nature; 2006 Feb; 439(7076):530. PubMed ID: 16452951
    [No Abstract]   [Full Text] [Related]  

  • 2. Wildlife biology. A devil of a disease.
    Bostanci A
    Science; 2005 Feb; 307(5712):1035. PubMed ID: 15718445
    [No Abstract]   [Full Text] [Related]  

  • 3. Tasmanian devil facial tumour disease: lessons for conservation biology.
    McCallum H
    Trends Ecol Evol; 2008 Nov; 23(11):631-7. PubMed ID: 18715674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced effect of Tasmanian devil facial tumor disease at the disease front.
    Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H
    Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of disease on the survival and population growth rate of the Tasmanian devil.
    Lachish S; Jones M; McCallum H
    J Anim Ecol; 2007 Sep; 76(5):926-36. PubMed ID: 17714271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil.
    Hollings T; Jones M; Mooney N; McCallum H
    Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researching the Tasmanian devil facial tumour.
    Harington JS
    Aust Vet J; 2006 May; 84(5):N26. PubMed ID: 16739522
    [No Abstract]   [Full Text] [Related]  

  • 8. Biting injuries and transmission of Tasmanian devil facial tumour disease.
    Hamede RK; McCallum H; Jones M
    J Anim Ecol; 2013 Jan; 82(1):182-90. PubMed ID: 22943286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devilish decline.
    Robertson H
    Curr Biol; 2005 Nov; 15(21):R858-9. PubMed ID: 16320397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allograft theory: transmission of devil facial-tumour disease.
    Pearse AM; Swift K
    Nature; 2006 Feb; 439(7076):549. PubMed ID: 16452970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission dynamics of Tasmanian devil facial tumor disease may lead to disease-induced extinction.
    McCallum H; Jones M; Hawkins C; Hamede R; Lachish S; Sinn DL; Beeton N; Lazenby B
    Ecology; 2009 Dec; 90(12):3379-92. PubMed ID: 20120807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-induced decline of an apex predator drives invasive dominated states and threatens biodiversity.
    Hollings T; Jones M; Mooney N; McCallum H
    Ecology; 2016 Feb; 97(2):394-405. PubMed ID: 27145614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To lose both would look like carelessness: Tasmanian devil facial tumour disease.
    McCallum H; Jones M
    PLoS Biol; 2006 Oct; 4(10):e342. PubMed ID: 17048985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
    Deakin JE; Belov K
    Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saving a species bedeviled by cancer.
    Harrington M
    Lab Anim (NY); 2011 Jul; 40(8):232. PubMed ID: 21772337
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii).
    Loh R; Hayes D; Mahjoor A; O'Hara A; Pyecroft S; Raidal S
    Vet Pathol; 2006 Nov; 43(6):896-903. PubMed ID: 17099146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease.
    Hamede RK; Beeton NJ; Carver S; Jones ME
    Sci Rep; 2017 Jul; 7(1):6217. PubMed ID: 28740255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tasmanian devil facial tumor disease: insights into reduced tumor surveillance from an unusual malignancy.
    O'Neill ID
    Int J Cancer; 2010 Oct; 127(7):1637-42. PubMed ID: 20473867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.